Return to homepagePandemic Pact

Collection of convalescent plasma for a prospective, randomized, placebo-controlled, double-blinded, phase IIb clinical trial of the therapeutic use of convalescent plasma in the treatment of patients with moderate to severe COVID-19

  • Funded by Department of Science and Innovation - South Africa
  • Total publications:0 publications
Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $209,989.5

  • Funder

    Department of Science and Innovation - South Africa

  • Principal Investigator

    N/A

  • Research Location

    South Africa

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Phase 2 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase II

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract